Cargando…
Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach
BACKGROUND: Novel pharmacological approaches are needed to improve the outcomes of patients with idiopathic pulmonary hypertension. Fatty acid synthase (FASN) inhibitors have shown beneficial effects in preclinical models of pulmonary arterial hypertension (PAH), because of their role in the regulat...
Autores principales: | Alsabeelah, Nimer, Kumar, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084994/ https://www.ncbi.nlm.nih.gov/pubmed/37051426 http://dx.doi.org/10.4103/jpbs.jpbs_307_22 |
Ejemplares similares
-
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
por: Cheng, Yusheng, et al.
Publicado: (2018) -
Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017) -
The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023) -
Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)